Cross Country Financials
CCRN Stock | USD 14.94 0.14 0.95% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.0088 | 0.0092 |
|
| |||||
Current Ratio | 2.63 | 2.7823 |
|
|
Investors should never underestimate Cross Country's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Cross Country's cash flow, debt, and profitability to make informed and accurate decisions about investing in Cross Country Healthcare.
Net Income |
|
Cross | Select Account or Indicator |
Understanding current and past Cross Country Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cross Country's financial statements are interrelated, with each one affecting the others. For example, an increase in Cross Country's assets may result in an increase in income on the income statement.
Cross Country Stock Summary
Cross Country competes with ASGN, Kforce, Kelly Services, AMN Healthcare, and Central Garden. Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company was founded in 1986 and is headquartered in Boca Raton, Florida. Cross Ctry operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 2250 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US2274831047 |
CUSIP | 227483104 22748P105 |
Location | Florida; U.S.A |
Business Address | 6551 Park of |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.crosscountry.com |
Phone | 561 998 2232 |
Currency | USD - US Dollar |
Cross Country Key Financial Ratios
Return On Equity | -0.0328 | ||||
Profit Margin | (0.01) % | ||||
Operating Margin | (0.01) % | ||||
Price To Sales | 0.37 X | ||||
Revenue | 1.34 B |
Cross Country Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 357.0M | 732.8M | 947.8M | 679.3M | 589.3M | 487.2M | |
Net Debt | 71.6M | 194.4M | 154.1M | (11.8M) | (77.8M) | (73.9M) | |
Cash | 1.6M | 1.0M | 3.6M | 17.1M | 81.6M | 85.7M | |
Other Assets | 18.3M | 35.8M | 33.5M | 36.8M | 33.1M | 20.3M | |
Total Liab | 202.1M | 435.3M | 490.6M | 205.9M | 170.3M | 199.0M | |
Total Current Assets | 183.1M | 508.3M | 675.7M | 415.2M | 335M | 207.3M | |
Other Current Liab | 23.5M | 70.4M | 254.6M | 115.9M | 88.0M | 92.4M | |
Retained Earnings | (154.7M) | (22.7M) | 165.7M | 238.4M | 218.1M | 229.0M | |
Accounts Payable | 49.9M | 109.8M | 12.9M | 3.0M | 5.7M | 5.5M | |
Long Term Debt | 71.0M | 53.4M | 176.4M | 148.7M | 171.0M | 179.6M | |
Net Receivables | 174.7M | 499.0M | 660.0M | 388.3M | 223.2M | 185.0M | |
Good Will | 90.9M | 119.5M | 163.3M | 135.4M | 135.1M | 128.3M | |
Other Current Assets | 6.8M | 8.3M | 12.1M | 9.7M | 30.1M | 31.6M | |
Short Term Debt | 6.9M | 12.4M | 4.1M | 2.6M | 2.1M | 2.0M | |
Intangible Assets | 40.7M | 48.2M | 44.7M | 54.5M | 42.2M | 40.1M | |
Other Liab | 43.4M | 40.0M | 48.3M | 65.4M | 75.2M | 78.9M | |
Inventory | 6.1M | 5.5M | 7.6M | 11.1M | 10.0M | 10.1M | |
Net Tangible Assets | 10.7M | 22.7M | 129.8M | 412.5M | 474.4M | 498.1M | |
Long Term Debt Total | 71.0M | 53.4M | 176.4M | 148.7M | 171.0M | 179.6M |
Cross Country Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 2.9M | 6.9M | 14.4M | 8.1M | 2.2M | 2.1M | |
Total Revenue | 836.4M | 1.7B | 2.8B | 2.0B | 1.3B | 915.3M | |
Gross Profit | 202.7M | 375.0M | 627.7M | 450.4M | 274.3M | 220.1M | |
Operating Income | 16.0M | 139.3M | 273.1M | 112.7M | (16.9M) | (16.0M) | |
Ebit | (13.8M) | 140.1M | 270.7M | 111.0M | (14.2M) | (13.5M) | |
Ebitda | 2.4M | 152.4M | 285.1M | 129.3M | 4.0M | 3.8M | |
Cost Of Revenue | 633.7M | 1.3B | 2.2B | 1.6B | 1.1B | 695.1M | |
Income Before Tax | (12.3M) | 133.2M | 256.3M | 102.9M | (16.4M) | (15.6M) | |
Net Income | (12.1M) | 132.0M | 188.5M | 72.6M | (14.6M) | (13.8M) | |
Income Tax Expense | (188K) | 1.2M | 67.9M | 30.3M | (1.8M) | (1.7M) | |
Non Recurring | 23.8M | 25.3M | 9.5M | 17.1M | 19.6M | 16.1M | |
Tax Provision | (188K) | 1.2M | 67.9M | 33.9M | (1.8M) | (1.7M) | |
Interest Income | 5.7M | 6.6M | 10K | 83K | 2.1M | 3.4M | |
Net Interest Income | (2.9M) | (6.9M) | (14.4M) | (11.0M) | (138K) | (144.9K) |
Cross Country Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change In Cash | 568K | (564K) | 2.6M | 13.5M | 64.5M | 67.8M | |
Free Cash Flow | 22.6M | (92.8M) | 125.3M | 234.5M | 111.4M | 117.0M | |
Depreciation | 12.7M | 9.9M | 12.6M | 18.3M | 18.2M | 11.7M | |
Other Non Cash Items | 25.1M | 12.8M | 26.7M | 22.2M | 24.8M | 26.0M | |
Capital Expenditures | 4.6M | 7.2M | 8.8M | 14.0M | 8.7M | 5.7M | |
Net Income | (12.1M) | 132.0M | 188.5M | 72.6M | (14.6M) | (13.8M) | |
End Period Cash Flow | 1.6M | 1.0M | 3.6M | 17.1M | 81.6M | 85.7M | |
Change To Inventory | 7.1M | 1.3M | (7.2M) | (83.3M) | (95.8M) | (100.6M) | |
Investments | (4.6M) | (34.0M) | (43.9M) | (48.0M) | (8.7M) | (9.1M) | |
Change Receivables | (6.6M) | (4.7M) | (318.4M) | (153.2M) | (137.9M) | (131.0M) | |
Net Borrowings | (91.9M) | (440.4M) | 127.7M | (38.5M) | (34.7M) | (36.4M) | |
Change To Netincome | 52.9M | 21.7M | (227.5M) | 22.0M | 19.8M | 20.8M |
Cross Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cross Country's current stock value. Our valuation model uses many indicators to compare Cross Country value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cross Country competition to find correlations between indicators driving Cross Country's intrinsic value. More Info.Cross Country Healthcare is number one stock in return on equity category among its peers. It is rated third in return on asset category among its peers . At this time, Cross Country's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cross Country's earnings, one of the primary drivers of an investment's value.Cross Country Healthcare Systematic Risk
Cross Country's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cross Country volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Cross Country Healthcare correlated with the market. If Beta is less than 0 Cross Country generally moves in the opposite direction as compared to the market. If Cross Country Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cross Country Healthcare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cross Country is generally in the same direction as the market. If Beta > 1 Cross Country moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Cross Country Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cross Country's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cross Country growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Cross Country March 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cross Country help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cross Country Healthcare. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cross Country Healthcare based on widely used predictive technical indicators. In general, we focus on analyzing Cross Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cross Country's daily price indicators and compare them against related drivers.
Information Ratio | (0.22) | |||
Maximum Drawdown | 6.99 | |||
Value At Risk | (1.67) | |||
Potential Upside | 0.5537 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.79) | Earnings Share (0.44) | Revenue Per Share | Quarterly Revenue Growth (0.25) | Return On Assets |
The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.